Literature DB >> 2959412

Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

J Z Wimperis1, M K Brenner, H G Drexler, A V Hoffbrand, H G Prentice.   

Abstract

Within the first year after T cell depleted bone marrow transplantation, co-cultures of T cells and non-T cells from 32 individual recipients examined on 43 occasions generally failed to produce increased quantities of immunoglobulin in response to stimulation with pokeweed mitogen or B cell differentiation factors. Failure occurred even in the presence of significant numbers of CD20 + ve B cells. The non-production of Ig appears to be due to a functional B cell defect, since adding marrow donor (syngeneic) T cells to recipient B cells in the presence of PWM or conditioned medium did not lead to immunoglobulin production. This B cell deficit persisted for 1 year. In contrast helper activity in the recipient T cell enriched population returns rapidly and by 6 weeks after transplant co-cultures of marrow donor B cells and recipient T cells produce comparable amounts of Ig to co-cultures of donor T and B cells. This prolonged defect of B cell function in vitro correlates with a year long delay before humoral responses to novel vaccine antigens can be elicited in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959412      PMCID: PMC1542360     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

Review 1.  Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis.

Authors:  G J Elfenbein; P N Anderson; R L Humphrey; G M Mullins; L L Sensenbrenner; J R Wands; G W Santos
Journal:  Transplant Proc       Date:  1976-12       Impact factor: 1.066

2.  Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).

Authors:  V Pistoia; F Cozzolino; M Torcia; E Castigli; M Ferrarini
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

3.  CD5-positive B cells after T cell depleted bone marrow transplantation.

Authors:  H G Drexler; M K Brenner; J Z Wimperis; S M Gignac; G Janossy; H G Prentice; A V Hoffbrand
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

Review 4.  Immunologic reconstitution after human marrow grafting.

Authors:  R P Witherspoon; L G Lum; R Storb
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

5.  B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation.

Authors:  S J Korsmeyer; G J Elfenbein; C K Goldman; S L Marshall; G W Santos; T A Waldmann
Journal:  Transplantation       Date:  1982-02       Impact factor: 4.939

6.  Production of antibody by human B cells under serum-free conditions.

Authors:  J Farrant; C A Newton; M E North; C Weyman; M K Brenner
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

7.  Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.

Authors:  H C Rümke; F G Terpstra; M T Roos; J M Vossen; L J Dooren; P T Schellekens; W P Zeijlemaker
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.

Authors:  H G Prentice; H A Blacklock; G Janossy; M J Gilmore; L Price-Jones; N Tidman; L K Trejdosiewicz; D B Skeggs; D Panjwani; S Ball
Journal:  Lancet       Date:  1984-03-03       Impact factor: 79.321

9.  Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune disease.

Authors:  M K Brenner; M E North
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

10.  Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients.

Authors:  S G Pahwa; R N Pahwa; W Friedrich; R J O'Reilly; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

View more
  2 in total

1.  Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.

Authors:  Y C Ng; J A Schifferli; M J Walport
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 2.  Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.

Authors:  Leslie S Kean
Journal:  Blood       Date:  2018-05-04       Impact factor: 25.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.